The importance of universal hereditary cancer testing

Universal cancer screening can be a powerful tool to help identify patients with genetic predispositions towards cancer. Cancers identified and treated at an early stage are more likely to have positive outcomes, using less invasive and less toxic treatments than required for more advanced disease. Yet, many patients who are eligible for these pan-cancer screenings are not aware that they quality, and some providers may also not realize it. In an interview with DocWire News, Evolent Medical Director Dr. Sadie Dobrozsi talk about the value of these genetic tests, the reasons why they often go underused, and how to close the gaps.

Watch video interview (8 minutes)